John H. Marburger III

During the height of the national ruckus over anthrax mailings and feared terrorist attacks this past October, the US Senate quietly confirmed John H. Marburger III as scientific adviser to President George W. Bush, and director of the Office of Science and Technology Policy (OSTP). Bush broke records for heel dragging in nominating a candidate and then demoted the position from assistant to the president, granting less face time with the chief of staff.1 Add to this the fact that the OSTP was r

Written byBrendan Maher
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

On top of already pressing issues such as climate change, stem cells, and cloning, that have given Bush more than his share of grief, Marburger has stepped in to advise on topics largely unthought of prior to the Sept. 11 terrorist attacks. Yet, Neal Lane, science adviser under President Bill Clinton, says Marburger is well suited to the job, calling him a consensus builder. His record tells a similar story as Marburger twice defused potentially volatile situations on Long Island, NY. He mediated a battle between community advocates and state officials over the Shoreham nuclear power facility and helped clean up the Department of Energy's once poorly managed Brookhaven National Laboratory.

Former New York Governor Mario Cuomo asked Marburger to head a fact-finding commission on Shoreham—the nuclear power plant that sparked quite a commotion but never a watt of electricity. David Sprintzen, who founded the Long Island Progressive Coalition in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies